A deletion of the long arm of chromosome 20 [del(20q)] is a recurring
abnormality in a wide spectrum of myeloid disorders. Loss of genetic m
aterial from 20q may confer a proliferative advantage to myeloid cells
, possibly through loss of function of a tumor suppressor gene. Previo
usly, we analyzed leukemia cells from 19 patients with a del(20q) by f
luorescence in situ hybridization (FISH) and identified a segment that
was deleted in 95% of all patients examined. The deleted interval ext
ended from 20q11.2 to q12, spanned approximately 13 Mb, and was flanke
d proximally by RPN2 and distally by D20S17. To narrow the commonly de
leted segment and facilitate the identification of candidate genes, we
have employed molecular approaches in combination with FISH. By using
21 microsatellite markers positioned in a recently generated physical
map of 20q, we performed allele loss studies in myeloid leukemia cell
s from 23 patients with a del(20q). The results of these studies allow
ed us to delineate a new proximal border, flanked by marker D20S206. B
y FISH analysis of additional leukemia samples from patients with a de
l(20q), we have also delineated a new distal boundary between markers
D20S119 and UT654. As a result of the redesignation of both the proxim
al and distal boundaries, we have successfully narrowed the commonly d
eleted segment within 20q12 to a region spanning approximately 8 Mb. I
dentification of the smallest deleted segment will facilitate the even
tual cloning of a candidate myeloid tumor suppressor gene. (C) 1998 Wi
ley-Liss, Inc.